Leo Pharma and Roche want to strengthen clinical research in Denmark
Administrative entities, universities, and the pharmaceutical industry at large have come together in a new task force, which includes representative from Leo Pharma and Roche Denmark, to secure better terms for Danish clinical research. (Corrected)
by ANDREAS LØNSTRUP, translated by daniel pedersen
(Corrected at 9:51 pm: Dorte Klokker was misquoted pertaining to the costs that the pharmaceutical industry bears for a patient receiving treatments during trials as opposed to standard care. The quote now reads: "We bear a lot of costs when it comes to working hours, drugs and scanning." MedWatch apologizes for the mistake.)
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lawyer leaves Novo Nordisk, joins Lundbeck
For subscribers
